Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Treatment of HER2-positive breast cancer: current status and future perspectives.
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma
Multidrug regimens for treatment of older patients with metastatic pancreatic cancer
